Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

PPIC

Introduction

For the institution with the same acronym, see Public Policy Institute of California.

Peptidyl-prolyl cis-trans isomerase C (PPIC) is an enzyme that in humans is encoded by the PPIC gene on chromosome 5. As a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family, this protein catalyzes the cis-trans isomerization of proline imidic peptide bonds, which allows it to facilitate folding or repair of proteins.[1][2][3] In addition, PPIC participates in many biological processes, including mitochondrial metabolism, apoptosis, redox, and inflammation, as well as in related diseases and conditions, such as ischemic reperfusion injury, AIDS, and cancer.[4][5][6][7]

Structure

Structure

Like other cyclophilins, PPIC forms a β-barrel structure with a hydrophobic core. This β-barrel is composed of eight anti-parallel β-strands and capped by two α-helices at the top and bottom. In addition, the β-turns and loops in the strands contribute to the flexibility of the barrel.[6] PPIC in particular is composed of 212 residues and contains a hydrophobic, ER-targeting sequence at the N-terminal. The PPIase domain is homologous to PPIA and can be bound and inhibited by CsA.[2]

Function

Function

The protein encoded by this gene is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins.[3] Generally, PPIases are found in all eubacteria and eukaryotes, as well as in a few archaebacteria, and thus are highly conserved.[4][8] The PPIase family is further divided into three structurally distinct subfamilies: cyclophilin (CyP), FK506-binding protein (FKBP), and parvulin (Pvn).[4][6] As a cyclophilin, PPI binds cyclosporin A (CsA) and can be found within in the cell or secreted by the cell.[5] In eukaryotes, cyclophilins localize ubiquitously to many cell and tissue types, though PPIC especially is highly expressed in kidney.[5][6][9] In addition to PPIase and protein chaperone activities, cyclophilins function in mitochondrial metabolism, apoptosis, immunological response, inflammation, and cell growth and proliferation.[4][5][6] Along with PPIB, PPIC localizes to the endoplasmic reticulum (ER), where it maintains redox homeostasis. Depletion of these two cyclophilins lead to hyperoxidation of the ER.[7] In the brain, PPIC complexes with cyclophilin C-associated protein (CyCAP) to activate microglia and macrophage function via the calcineurin/NFAT pathway.[9]

Clinical Significance

Clinical Significance

As a cyclophilin, PPIC binds the immunosuppressive drug CsA to form a CsA-cyclophilin complex, which then targets calcineurin to inhibit the signaling pathway for T-cell activation.[5]

In cardiac myogenic cells, cyclophilins have been observed to be activated by heat shock and hypoxia-reoxygenation as well as complex with heat shock proteins. Thus, cyclophilins may function in cardioprotection during ischemia-reperfusion injury.[5] Similarly, PPIC may confer neuroprotection by forming a complex with CyCAP to activate survival mechanisms and mitigate ischemic damage in the brain.[9]

Currently, cyclophilin expression is highly correlated with cancer pathogenesis, but the specific mechanisms remain to be elucidated.[5] For instance, studies identify PPIC as a reliable indicator of circulating tumor cells in epithelial ovarian cancer (EOC) and, thus, may serve as a biomarker for detection and treatment of the cancer.[10]

Interactions

Interactions

PPIC has been shown to interact with:

References

References

  1. ↑ Sugano S, Kim DW, Yu YS, Mizushima-Sugano J, Yoshitomo K, Watanabe S, Suzuki F, Yamaguchi N (Oct 1992). “Use of an epitope-tagged cDNA library to isolate cDNAs encoding proteins with nuclear localization potential”. Gene. 120 (2): 227–33. doi:10.1016/0378-1119(92)90097-9. PMID 1383094.
  2. ↑ 2.0 2.1 Schneider H, Charara N, Schmitz R, Wehrli S, Mikol V, Zurini MG, Quesniaux VF, Movva NR (Jul 1994). “Human cyclophilin C: primary structure, tissue distribution, and determination of binding specificity for cyclosporins”. Biochemistry. 33 (27): 8218–24. doi:10.1021/bi00193a007. PMID 8031755.
  3. ↑ 3.0 3.1 “Entrez Gene: PPIC peptidylprolyl isomerase C (cyclophilin C)”.
  4. ↑ 4.0 4.1 4.2 4.3 Kazui T, Inoue N, Yamada O, Komatsu S (Jan 1992). “Selective cerebral perfusion during operation for aneurysms of the aortic arch: a reassessment”. The Annals of Thoracic Surgery. 53 (1): 109–14. doi:10.1016/0003-4975(92)90767-x. PMID 1530810.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Yao Q, Li M, Yang H, Chai H, Fisher W, Chen C (Mar 2005). “Roles of cyclophilins in cancers and other organ systems”. World Journal of Surgery. 29 (3): 276–80. doi:10.1007/s00268-004-7812-7. PMID 15706440.
  6. ↑ 6.0 6.1 6.2 6.3 6.4 Wang T, Yun CH, Gu SY, Chang WR, Liang DC (Aug 2005). “1.88 A crystal structure of the C domain of hCyP33: a novel domain of peptidyl-prolyl cis-trans isomerase”. Biochemical and Biophysical Research Communications. 333 (3): 845–9. doi:10.1016/j.bbrc.2005.06.006. PMID 15963461.
  7. ↑ 7.0 7.1 Stocki P, Chapman DC, Beach LA, Williams DB (Aug 2014). “Depletion of cyclophilins B and C leads to dysregulation of endoplasmic reticulum redox homeostasis”. The Journal of Biological Chemistry. 289 (33): 23086–96. doi:10.1074/jbc.M114.570911. PMC 4132807. PMID 24990953.
  8. ↑ Hoffmann H, Schiene-Fischer C (Jul 2014). “Functional aspects of extracellular cyclophilins”. Biological Chemistry. 395 (7–8): 721–35. doi:10.1515/hsz-2014-0125. PMID 24713575.
  9. ↑ 9.0 9.1 9.2 9.3 9.4 9.5 9.6 Yamaguchi R, Hosaka M, Torii S, Hou N, Saito N, Yoshimoto Y, Imai H, Takeuchi T (Jun 2011). “Cyclophilin C-associated protein regulation of phagocytic functions via NFAT activation in macrophages”. Brain Research. 1397: 55–65. doi:10.1016/j.brainres.2011.03.036. PMID 21435337.
  10. ↑ Obermayr E, Castillo-Tong DC, Pils D, Speiser P, Braicu I, Van Gorp T, Mahner S, Sehouli J, Vergote I, Zeillinger R (Jan 2013). “Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance — a study of the OVCAD consortium”. Gynecologic Oncology. 128 (1): 15–21. doi:10.1016/j.ygyno.2012.09.021. PMID 23017820.
  11. ↑ 11.0 11.1 Trahey M, Weissman IL (Mar 1999). “Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo”. Proceedings of the National Academy of Sciences of the United States of America. 96 (6): 3006–11. doi:10.1073/pnas.96.6.3006. PMC 15885. PMID 10077627.
Further reading

Further reading